USPTO serial 79344278
DIVITUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 8, 2023
- Examiner
- LOZEAU, BRANDON THOMAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DIVITUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark H. Tidman
Mark H. Tidman Baker & Hostetler LLP1050 Connecticut Ave, NWWashington Square, Suite 1100Washington, DC 20036-5403Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use | ACTIVE | — |
| 005 | Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases | ACTIVE | — |
| 042 | Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity | ACTIVE | — |
| 044 | Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biovica International AB
- Other trademarks owned by Biovica International AB
- Other trademarks owned by Biovica International AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DIVITUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 13, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 13, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 8, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 8, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 8, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 3, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 6, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 6, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 29, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 29, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 3, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 2, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 24, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 24, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 24, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 24, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 10, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 10, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 10, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 10, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 10, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 10, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |